|
1
|
Cho NH, Shaw JE, Karuranga S, Huang Y, da
Rocha Fernandes JD, Ohlrogge AW and Malanda B: IDF Diabetes Atlas:
Global estimates of diabetes prevalence for 2017 and projections
for 2045. Diabetes Res Clin Pract. 138:271–281. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
American Diabetes Association: 2.
Classification and diagnosis of diabetes. Diabetes Care. 39 (Suppl
1):S13–S22. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mathers CD and Loncar D: Projections of
global mortality and burden of disease from 2002 to 2030. PLoS Med.
3:e4422006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Michael J and Fowler M: Microvascular and
macrovascular complications of diabetes. Clin Diabetes. 26:77–82.
2008. View Article : Google Scholar
|
|
5
|
Morrish NJ, Wang SL, Stevens LK, Fuller JH
and Keen H: Mortality and causes of death in the WHO multinational
study of vascular disease in diabetes. Diabetologia. 44 (Suppl
2):S14–S21. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang D, Refaat M, Mohammedi K, Jayyousi
A, Al Suwaidi J and Abi Khalil C: Macrovascular complications in
patients with diabetes and prediabetes. Biomed Res Int.
2017:78391012017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang B, Yang J, Bai J, Pu P, Liu J, Wang F
and Ruan B: Suv39h1 protects from myocardial ischemia-reperfusion
injury in diabetic rats. Cell Physiol Biochem. 33:1176–1185. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang ZV and Hill JA: Diabetic
cardiomyopathy: Catabolism driving metabolism. Circulation.
131:771–773. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
D'Souza A, Howarth FC, Yanni J, Dobryznski
H, Boyett MR, Adeghate E, Bidasee KR and Singh J: Left ventricle
structural remodelling in the prediabetic Goto-Kakizaki rat. Exp
Physiol. 96:875–888. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee JC, Laydon JT, McDonnell PC, Gallagher
TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter
SW, et al: A protein kinase involved in the regulation of
inflammatory cytokine biosynthesis. Nature. 372:739–746. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Han J, Lee JD, Bibbs L and Ulevitch RJ: A
MAP kinase targeted by endotoxin and hyperosmolarity in mammalian
cells. Science. 265:808–811. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gao Y, Kang L, Li C, Wang X, Sun C, Li Q,
Liu R and Wang J: Resveratrol ameliorates diabetes-induced cardiac
dysfunction through AT1R-ERK/p38 MAPK signaling pathway. Cardiovasc
Toxicol. 16:130–137. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shi L, Yu X, Yang H and Wu X: Advanced
glycation end products induce human corneal epithelial cells
apoptosis through generation of reactive oxygen species and
activation of JNK and p38 MAPK pathways. PLoS One. 8:e667812013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang J, Guo X, Yang J, Ding JW, Li S, Yang
R, Fan ZX and Yang CJ: RP105 protects against apoptosis in
ischemia/reperfusion-induced myocardial damage in rats by
suppressing TLR4-mediated signaling pathways. Cell Physiol Biochem.
36:2137–2148. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kumphune S, Chattipakorn S and
Chattipakorn N: Role of p38 inhibition in cardiac
ischemia/reperfusion injury. Eur J Clin Pharmacol. 68:513–524.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sasaki H, Asanuma H, Fujita M, Takahama H,
Wakeno M, Ito S, Ogai A, Asakura M, Kim J, Minamino T, et al:
Metformin prevents progression of heart failure in dogs: Role of
AMP-activated protein kinase. Circulation. 119:2568–2577. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gundewar S, Calvert JW, Jha S,
Toedt-Pingel I, Ji SY, Nunez D, Ramachandran A, Anaya-Cisneros M,
Tian R and Lefer DJ: Activation of AMP-activated protein kinase by
metformin improves left ventricular function and survival in heart
failure. Circ Res. 104:403–411. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu M, Ye P, Liao H, Chen M and Yang F:
Metformin protects H9C2 cardiomyocytes from High-glucose and
hypoxia/reoxygenation injury via inhibition of reactive oxygen
species generation and inflammatory responses: Role of AMPK and
JNK. J Diabetes Res. 2016:29619542016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu W, Wu W, Chen J, Guo R, Lin J, Liao X
and Feng J: Exogenous hydrogen sulfide protects H9c2 cardiac cells
against high glucose-induced injury by inhibiting the activities of
the p38 MAPK and ERK1/2 pathways. Int J Mol Med. 32:917–925. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li K, Cui YC, Zhang H, Liu XP, Zhang D, Wu
AL, Li JJ and Tang Y: Glutamine reduces the apoptosis of H9C2 cells
treated with High-glucose and reperfusion through an
Oxidation-related mechanism. PLoS One. 10:e01324022015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li YG, Han BB, Li F, Yu JW, Dong ZF, Niu
GM, Qing YW, Li JB, Wei M and Zhu W: High Glucose induces
down-regulated GRIM-19 expression to activate STAT3 signaling and
promote cell proliferation in cell culture. PLoS One.
11:e01536592016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu ZW, Zhu HT, Chen KL, Dong X, Wei J,
Qiu C and Xue JH: Protein kinase RNA-like endoplasmic reticulum
kinase (PERK) signaling pathway plays a major role in reactive
oxygen species (ROS)-mediated endoplasmic reticulum stress-induced
apoptosis in diabetic cardiomyopathy. Cardiovasc Diabetol.
12:1582013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Paiyabhroma N, Nernpermpisooth N and
Kumphune S: The recombinant human secretory leukocyte protease
inhibitor (SLPI) protects cardiac fibroblasts injury against an in
vitro ischemia/reperfusion injury. J Appl Pharm Sci. 8:156–162.
2018. View Article : Google Scholar
|
|
24
|
Kumphune S, Chattipakorn S and
Chattipakorn N: Roles of p38-MAPK in insulin resistant heart:
Evidence from bench to future bedside application. Curr Pharm Des.
19:5742–5754. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kravchuk E, Grineva E, Bairamov A,
Galagudza M and Vlasov T: The effect of metformin on the myocardial
tolerance to ischemia-reperfusion injury in the rat model of
diabetes mellitus type II. Exp Diabetes Res. 2011:9074962011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen P, Yuan Y, Zhang T, Xu B, Gao Q and
Guan T: Pentosan polysulfate ameliorates apoptosis and inflammation
by suppressing activation of the p38 MAPK pathway in high
glucosetreated HK2 cells. Int J Mol Med. 41:908–914.
2018.PubMed/NCBI
|
|
27
|
Vahtola E, Louhelainen M, Forstén H,
Merasto S, Raivio J, Kaheinen P, Kytö V, Tikkanen, Levijoki J and
Mervaala E: Sirtuin1-p53, forkhead box O3a, p38 and post-infarct
cardiac remodeling in the spontaneously diabetic Goto-Kakizaki rat.
Cardiovasc Diabetol. 9:52010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kumphune S, Surinkaew S, Chattipakorn SC
and Chattipakorn N: Inhibition of p38 MAPK activation protects
cardiac mitochondria from ischemia/reperfusion injury. Pharm Biol.
53:1831–1841. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Driver C, Bamitale KDS, Kazi A, Olla M,
Nyane NA and Owira PMO: Cardioprotective effects of metformin. J
Cardiovasc Pharmacol. 72:121–127. 2018.PubMed/NCBI
|
|
30
|
Seshadri KG: Non obesity, autoimmunity and
the missing pieces of diabetes in the adult. Int J Diabetes Dev
Ctries. 33:69–70. 2013. View Article : Google Scholar
|
|
31
|
Vaag A and Lund SS: Non-obese patients
with type 2 diabetes and prediabetic subjects: Distinct phenotypes
requiring special diabetes treatment and (or) prevention? Appl
Physiol Nutr Metab. 32:912–920. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kashima S, Inoue K, Matsumoto M and
Akimoto K: Prevalence and characteristics of non-obese diabetes in
Japanese men and women: The Yuport medical checkup center study. J
Diabetes. 7:523–530. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
American Diabetes Associatio: Standards of
medical care in diabetes-2017 abridged for primary care providers.
Clin Diabetes. 35:5–26. 2017.PubMed/NCBI
|
|
34
|
Ahmad T, Ohlsson C, Sääf M, Ostenson CG
and Kreicbergs A: Skeletal changes in type-2 diabetic Goto-Kakizaki
rats. J Endocrinol. 178:111–116. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kuwabara WMT, Panveloski-Costa AC, Yokota
CNF, Pereira JNB, Filho JM, Torres RP, Hirabara SM, Curi R and
Alba-Loureiro TC: Comparison of Goto-Kakizaki rats and high fat
diet-induced obese rats: Are they reliable models to study Type 2
diabetes mellitus? PLoS One. 12:e01896222017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hansson LI, Menander-Sellman K, Stenström
A and Thorngren KG: Rate of normal longitudinal bone growth in the
rat. Calcif Tissue Res. 10:238–251. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yoshida T, Okuno A, Tanaka J, Takahashi K,
Nakashima R, Kanda S, Ogawa J, Hagisawa Y and Fujiwara T: Metformin
primarily decreases plasma glucose not by gluconeogenesis
suppression but by activating glucose utilization in a non-obese
type 2 diabetes Goto-Kakizaki rats. Eur J Pharmacol. 623:141–147.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Oh TJ, Shin JY, Kang GH, Park KS and Cho
YM: Effect of the combination of metformin and fenofibrate on
glucose homeostasis in diabetic Goto-Kakizaki rats. Exp Mol Med.
45:e302013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Carlson CJ and Rondinone CM:
Pharmacological inhibition of p38 MAP kinase results in improved
glucose uptake in insulin-resistant 3T3-L1 adipocytes. Metabolism.
54:895–901. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bazuine M, Carlotti F, Rabelink MJ,
Vellinga J, Hoeben RC and Maassen JA: The p38 mitogen-activated
protein kinase inhibitor SB203580 reduces glucose turnover by the
glucose transporter-4 of 3T3-L1 adipocytes in the
insulin-stimulated state. Endocrinology. 146:1818–1824. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Burns CJ, Howell SL, Jones PM and Persaud
SJ: The p38 mitogen-activated protein kinase cascade is not
required for the stimulation of insulin secretion from rat islets
of Langerhans. Mol Cell Endocrinol. 148:29–35. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Vahtola E, Storvik M, Louhelainen M,
Merasto S, Lakkisto P, Lakkisto J, Tikkanen I, Kaheinen P, Levijoki
J and Mervaala E: Effects of levosimendan on cardiac gene
expression profile and post-infarct cardiac remodelling in diabetic
Goto-Kakizaki rats. Basic Clin Pharmacol Toxicol. 109:387–397.
2011. View Article : Google Scholar : PubMed/NCBI
|
